UK Markets closed
  • NIKKEI 225

    28,523.26
    -110.24 (-0.39%)
     
  • HANG SENG

    29,962.47
    +320.19 (+1.08%)
     
  • CRUDE OIL

    53.28
    +0.04 (+0.08%)
     
  • GOLD FUTURES

    1,871.20
    +4.70 (+0.25%)
     
  • DOW

    31,188.38
    +257.86 (+0.83%)
     
  • BTC-GBP

    26,019.31
    +807.26 (+3.20%)
     
  • CMC Crypto 200

    696.42
    -4.19 (-0.60%)
     
  • Nasdaq

    13,457.25
    +260.07 (+1.97%)
     
  • ^FTAS

    3,816.31
    +22.40 (+0.59%)
     

Director Share Purchase

·2-min read

Arix Bioscience PLC (ARIX)
21-Dec-2020 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

Arix Bioscience plc

Director Share Purchase

 

LONDON, 21 December 2020: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that Naseem Amin, Executive Chairman, purchased 183,000 ordinary shares ("Ordinary Shares") in the Company on 18 December 2020 at a price of 206p per share, via a corporate entity in which he has a majority beneficial interest.

 

The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the transaction in number of Ordinary Shares.

 

 

 

For further information:

 

Robert Lyne Chief Operating Officer and General Counsel +44 (0)207 290 1050

 

 

 - Ends -


 PDMR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Naseem Amin

2

Reason for the notification

a)

Position / status

Executive Chairman

b)

Initial notification /

Amendment

Initial Notification

3

Details of issuer

a)

Name

Arix Bioscience plc

b)

LEI

213800OVT3AHQCXNIX43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Arix Bioscience plc

Identification code

GB00BD045071

b)

Nature of the transaction

Purchase of Ordinary Shares by Davum Capital Limited, a corporate entity in which Naseem Amin has a majority beneficial interest

c)

Price(s) and volume(s)

Price(s)

Volume(s)

206.00p

183,000

d)

Aggregated information

Aggregated price

Aggregated volume

N/A (single transaction)

N/A (single transaction)

e)

Date of the transaction

18 December 2020

f)

Place of the transaction

London Stock Exchange (XLON)

 PDMR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Naseem Amin

2

Reason for the notification

a)

Position / status

Executive Chairman

b)

Initial notification /

Amendment

Initial Notification

3

Details of issuer

a)

Name

Arix Bioscience plc

b)

LEI

213800OVT3AHQCXNIX43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Arix Bioscience plc

Identification code

GB00BD045071

b)

Nature of the transaction

Purchase of Ordinary Shares by Davum Capital Limited, a corporate entity in which Naseem Amin has a majority beneficial interest

c)

Price(s) and volume(s)

Price(s)

Volume(s)

206.00p

183,000

d)

Aggregated information

Aggregated price

Aggregated volume

N/A (single transaction)

N/A (single transaction)

e)

Date of the transaction

18 December 2020

f)

Place of the transaction

London Stock Exchange (XLON)

ISIN:

GB00BD045071

Category Code:

DSH

TIDM:

ARIX

LEI Code:

213800OVT3AHQCXNIX43

Sequence No.:

90018

EQS News ID:

1156507


 

End of Announcement

EQS News Service

show this
show this